Skip to main content
Log in

Effective stimulation of neutropoiesis with rh G-CSF in dyskeratosis congenita: a case report

  • Case Report
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Summary

Dyskeratosis congenita (DC) is a rare congenital X-linked disorder. The major clinical manifestations are abnormal skin pigmentation, nail dystrophy, and leukoplakia of mucosal membranes. About 50% of the patients develop bone marrow failure, which is partly responsible for the poor prognosis. Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) has been administered to some neutropenic patients with DC, but only a moderate stimulation of neutropoiesis has been observed. We report on a patient with DC treated with recombinant human granulocyte-colony-stimulating factor (rhG-CSF). This treatment resulted in a substantial dose-dependent increase in the neutrophil count.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bonilla MA, Gillio A, Ruggeiro M, Kernan N, Brachstein J, Abboud M, Fumagalli L, Vincent M, Gabrilove J, Welte K, Souza L, O'Reilly R (1989) Effects of recombinant human colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med 320:1574–1580

    PubMed  Google Scholar 

  2. Colvin BT, Baker H, Hibbin JA, Gordon-Smith EC, Gordon MY (1984) Haematopoietic progenitor cells in dyskeratosis congenita. Br J Haematol 56:513–517

    PubMed  Google Scholar 

  3. Connor JM, Gatherer D, Gray FC, Pirrit LA, Affara NA (1986) Assignment of the gene for dyskeratosis congenita to Xq28. Hum Genet 72:348

    PubMed  Google Scholar 

  4. Dokal I, Bungey J, Williamson P, Oscier D, Hows J, Luzzato L (1992) Dyskeratosis congenita fibroblasts are abnormal and have unbalanced chromosomal rearrangements. Blood 80:3090–3096

    PubMed  Google Scholar 

  5. Freund M, Luft St, Schöber Ch, Heussner P, Schrezenmaier H, Porzsolt F, Weite K (1990) Differential effect of GM-CSF and G-CSF in cyclic neutropenia. Lancet 336:313

    PubMed  Google Scholar 

  6. Friedland M, Lutton JD, Spitzer R, Levere RD (1985) Dyskeratosis congenita with hypoplastic anemia: a stem cell defect. Am J Hematol 20:85–87

    PubMed  Google Scholar 

  7. Hess U, Ganser A, Schnurch HG, Seipelt G, Ottmann OG, Schulz G, Hoelzer D (1992) Myelokathexis treated with recombinant human granulocyte-macrophage colony-stimulating factor (rh GM-CSF). Br J Haematol 80:254–256

    PubMed  Google Scholar 

  8. Marsch JCW, Will AJ, Hows JM, Sartori P, Darbyshire PJ, Williamson PJ, Oscier DG, Dexter M, Testa NG (1992) “Stem cell” origin of the hemopoietic defect in dyskeratosis congenita. Blood 79:3138–3144

    PubMed  Google Scholar 

  9. Migliaccio AR, Migliaccio G, Dale DC, Hammond WP (1990) Hematopoietic progenitors in cyclic neutropenia: effect of granulocyte-colony stimulating factor in vivo. Blood 75:1951–1959

    PubMed  Google Scholar 

  10. Naoto A, Hiroyuki T, Hiroyuki N, Shigenori H, Izumi A, Shouji C (1990) rh G-CSF for Shwachman's syndrome. Lancet 336:1136

    Google Scholar 

  11. Putterman C, Safadi R, Zlotogora J, Banura R, Eldor A (1993) Treatment of the hematological manifestations of dyskeratosis congenita. Ann Hematol 66:209–212

    PubMed  Google Scholar 

  12. Russo CL, Glader BE, Israel RJ, Galasso F (1990) Treatment of neutropenia associated with dyskeratosis congenita with granulocyte-macrophage colony-stimulating factor. Lancet 336:751–752

    PubMed  Google Scholar 

  13. Schneider A, Mayer U, Gebhart E, Harma D, Gromball J, Glockell U, Beck JD (1988) Clastogen-induced fragility may differentiate pancytopenia of congenital dyskeratosis from Fanconi anemia. Eur J Pediatr 148:37

    PubMed  Google Scholar 

  14. Schroter H, Roesler J, Breidenbach T, Wendel U, Elsner J, Schweitzer S, Zeidler C, Burdach S, Lohmann-Matthes ML, Wahn V, Welte K (1991) Granulocyte and granulocyte-macrophage colony-stimulating factors for treatment of neutropenia in glycogen storage disease type Ib. J Pediatr 119:748–754

    PubMed  Google Scholar 

  15. Teague RH, Connor JM (1981) Dyskeratosis congenita. Report of a large kindred. Br J Dermatol 105:321–325

    PubMed  Google Scholar 

  16. Welte K, Zeidler C, Reiter A, Müller W, Odenwald E, Souza L, Riehm H (1990) Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia. Blood 75:1056–1063

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oehler, L., Reiter, E., Friedl, J. et al. Effective stimulation of neutropoiesis with rh G-CSF in dyskeratosis congenita: a case report. Ann Hematol 69, 325–327 (1994). https://doi.org/10.1007/BF01696564

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01696564

Key words

Navigation